Techovet Pharma Profile
Key Indicators
- Authorised Capital ₹ 1.20 M
- Paid Up Capital ₹ 1.20 M
- Company Age 13 Year, 11 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth 18.17%
- Profit Growth 14.97%
- Ebitda 691.78%
- Net Worth 22.55%
- Total Assets 19.03%
About Techovet Pharma
Techovet Pharma Private Limited (TPPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 24 February 2011 and has a history of 13 years and 11 months. Its registered office is in Ambala, Haryana, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.20 M and a paid-up capital of Rs 1.20 M, as per Ministry of Corporate Affairs (MCA) records.
Ram Kumar, Yudhvir Singh, Manjeet Singh, and Four other members serve as directors at the Company.
Company Details
-
Location
Ambala, Haryana, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U51397HR2011PTC042212
-
Company No.
042212
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
24 Feb 2011
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Delhi
Industry
Who are the key members and board of directors at Techovet Pharma?
Board Members (7)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ram Kumar
|
Director | 24-Feb-2011 | Current |
|
Yudhvir Singh
|
Director | 24-Feb-2011 | Current |
|
Manjeet Singh
|
Director | 24-Feb-2011 | Current |
|
Mukesh Kalyan
|
Director | 24-Feb-2011 | Current |
|
Arvind Kumar
|
Director | 24-Feb-2011 | Current |
|
Naresh Kumar
|
Director | 12-Jan-2013 | Current |
Financial Performance of Techovet Pharma.
Techovet Pharma Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 18.17% increase. The company also saw a substantial improvement in profitability, with a 14.97% increase in profit. The company's net worth Soared by an impressive increase of 22.55%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Techovet Pharma?
In 2021, Techovet Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Gurshyam Formulations Private LimitedRam Kumar is a mutual person
-
Ridhi Sidhi Foodzone Private LimitedRam Kumar is a mutual person
-
Moramadhav Milk Products Private Limited
Ram Kumar is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Techovet Pharma?
Techovet Pharma has a workforce of 70 employees as of Apr 03, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Techovet Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Techovet Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
